The Angiopoietin Related Protein 3 pipeline drugs market research report outlays comprehensive information on the Angiopoietin Related Protein 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Angiopoietin Related Protein 3 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Musculoskeletal Disorders, and Genito Urinary System which include the indications Hypertriglyceridemia, Homozygous Familial Hypercholesterolemia (HoFH), Atherosclerosis, Osteoarthritis, and Chronic Kidney Disease (Chronic Renal Failure). It also reviews key players involved in Angiopoietin Related Protein 3 targeted therapeutics development with respective active and dormant or discontinued products.
The Angiopoietin Related Protein 3 pipeline targets constitutes close to 17 molecules. Out of which, approximately 17 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, IND/ CTA Filed, Preclinical, and Discovery stages are 1, 5, 4, 1, 4, and 2 respectively.
Angiopoietin Related Protein 3 overview
Angiopoietin-like 3 (ANGPTL3) is a protein that function in angiogenesis. Expressed predominantly in the liver, it is further processed into an N-terminal coiled-coil domain-containing chain and a C-terminal fibrinogen chain. The N-terminal chain is important for lipid metabolism, while the C-terminal chain may be involved in angiogenesis.
For a complete picture of Angiopoietin Related Protein 3’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.